70 related articles for article (PubMed ID: 38616918)
21. Veno-occlusive disease in children and adolescents after hematopoietic stem cell transplantation: Did the Modified Seattle Criteria fit the characteristics of pediatric population?
Szmit Z; Gorczyńska E; Mielcarek-Siedziuk M; Ussowicz M; Owoc-Lempach J; Kałwak K
Adv Clin Exp Med; 2020 Mar; 29(3):339-344. PubMed ID: 32207590
[TBL] [Abstract][Full Text] [Related]
22. Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD).
Yoon JH; Yoo KH; Sung KW; Jung CW; Kim JS; Hahn SM; Kang HJ; Lee JH; Im HJ; Ahn JS; Kook H; Cho B; Lee JW
Bone Marrow Transplant; 2019 Aug; 54(8):1361-1368. PubMed ID: 30809031
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome.
Kammersgaard MB; Kielsen K; Heilmann C; Ifversen M; Müller K
Bone Marrow Transplant; 2019 Sep; 54(9):1406-1418. PubMed ID: 30683907
[TBL] [Abstract][Full Text] [Related]
24. Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant.
Strouse C; Zhang Y; Zhang MJ; DiGilio A; Pasquini M; Horowitz MM; Lee S; Ho V; Ramanathan M; Chinratanalab W; Loren A; Burns LJ; Artz A; Villa KF; Saber W
Biol Blood Marrow Transplant; 2018 Oct; 24(10):2072-2080. PubMed ID: 29928989
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.
Corbacioglu S; Carreras E; Ansari M; Balduzzi A; Cesaro S; Dalle JH; Dignan F; Gibson B; Guengoer T; Gruhn B; Lankester A; Locatelli F; Pagliuca A; Peters C; Richardson PG; Schulz AS; Sedlacek P; Stein J; Sykora KW; Toporski J; Trigoso E; Vetteranta K; Wachowiak J; Wallhult E; Wynn R; Yaniv I; Yesilipek A; Mohty M; Bader P
Bone Marrow Transplant; 2018 Feb; 53(2):138-145. PubMed ID: 28759025
[TBL] [Abstract][Full Text] [Related]
26. Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 1: Focus on Investigations, Prophylaxis, and Specific Treatment.
Bajwa RPS; Mahadeo KM; Taragin BH; Dvorak CC; McArthur J; Jeyapalan A; Duncan CN; Tamburro R; Gehred A; Lehmann L; Richardson P; Auletta JJ; Woolfrey AE
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1817-1825. PubMed ID: 28754544
[TBL] [Abstract][Full Text] [Related]
27. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
[TBL] [Abstract][Full Text] [Related]
28. Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.
Bartelink IH; Lalmohamed A; van Reij EM; Dvorak CC; Savic RM; Zwaveling J; Bredius RG; Egberts AC; Bierings M; Kletzel M; Shaw PJ; Nath CE; Hempel G; Ansari M; Krajinovic M; Théorêt Y; Duval M; Keizer RJ; Bittencourt H; Hassan M; Güngör T; Wynn RF; Veys P; Cuvelier GD; Marktel S; Chiesa R; Cowan MJ; Slatter MA; Stricherz MK; Jennissen C; Long-Boyle JR; Boelens JJ
Lancet Haematol; 2016 Nov; 3(11):e526-e536. PubMed ID: 27746112
[TBL] [Abstract][Full Text] [Related]
29. High Variability in the Reported Management of Hepatic Veno-Occlusive Disease in Children after Hematopoietic Stem Cell Transplantation.
Skeens MA; McArthur J; Cheifetz IM; Duncan C; Randolph AG; Stanek J; Lehman L; Bajwa R;
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1823-1828. PubMed ID: 27496218
[TBL] [Abstract][Full Text] [Related]
30. Performance of Busulfan Dosing Guidelines for Pediatric Hematopoietic Stem Cell Transplant Conditioning.
Zao JH; Schechter T; Liu WJ; Gerges S; Gassas A; Egeler RM; Grunebaum E; Dupuis LL
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1471-8. PubMed ID: 25977229
[TBL] [Abstract][Full Text] [Related]
31. Implementation science in pediatric health care: advances and opportunities.
Wittmeier KD; Klassen TP; Sibley KM
JAMA Pediatr; 2015 Apr; 169(4):307-9. PubMed ID: 25706238
[No Abstract] [Full Text] [Related]
32. Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics.
ten Brink MH; Zwaveling J; Swen JJ; Bredius RG; Lankester AC; Guchelaar HJ
Drug Discov Today; 2014 Oct; 19(10):1572-86. PubMed ID: 24747172
[TBL] [Abstract][Full Text] [Related]
33. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.
Corbacioglu S; Cesaro S; Faraci M; Valteau-Couanet D; Gruhn B; Rovelli A; Boelens JJ; Hewitt A; Schrum J; Schulz AS; Müller I; Stein J; Wynn R; Greil J; Sykora KW; Matthes-Martin S; Führer M; O'Meara A; Toporski J; Sedlacek P; Schlegel PG; Ehlert K; Fasth A; Winiarski J; Arvidson J; Mauz-Körholz C; Ozsahin H; Schrauder A; Bader P; Massaro J; D'Agostino R; Hoyle M; Iacobelli M; Debatin KM; Peters C; Dini G
Lancet; 2012 Apr; 379(9823):1301-9. PubMed ID: 22364685
[TBL] [Abstract][Full Text] [Related]
34. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade.
Carreras E; Díaz-Beyá M; Rosiñol L; Martínez C; Fernández-Avilés F; Rovira M
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1713-20. PubMed ID: 21708110
[TBL] [Abstract][Full Text] [Related]
35. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.
Coppell JA; Richardson PG; Soiffer R; Martin PL; Kernan NA; Chen A; Guinan E; Vogelsang G; Krishnan A; Giralt S; Revta C; Carreau NA; Iacobelli M; Carreras E; Ruutu T; Barbui T; Antin JH; Niederwieser D
Biol Blood Marrow Transplant; 2010 Feb; 16(2):157-68. PubMed ID: 19766729
[TBL] [Abstract][Full Text] [Related]
36. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Cesaro S; Pillon M; Talenti E; Toffolutti T; Calore E; Tridello G; Strugo L; Destro R; Gazzola MV; Varotto S; Errigo G; Carli M; Zanesco L; Messina C
Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577
[TBL] [Abstract][Full Text] [Related]
37. Venoocclusive disease of the liver following bone marrow transplantation.
Jones RJ; Lee KS; Beschorner WE; Vogel VG; Grochow LB; Braine HG; Vogelsang GB; Sensenbrenner LL; Santos GW; Saral R
Transplantation; 1987 Dec; 44(6):778-83. PubMed ID: 3321587
[TBL] [Abstract][Full Text] [Related]
38. Retrospective analysis of veno-occlusive disease/sinusoidal obstruction syndrome in paediatric patients undergoing hematopoietic cell transplantation -a multicentre study.
Ragoonanan D; Abdel-Azim H; Sharma A; Bhar S; McArthur J; Madden R; Rahrig A; Bajwa R; Wang J; Sun V; Wright M; Lassiter R; Shoberu B; Kawedia J; Khazal SJ; Mahadeo KM;
Lancet Reg Health Am; 2024 May; 33():100728. PubMed ID: 38616918
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement.
Mahadeo KM; Bajwa R; Abdel-Azim H; Lehmann LE; Duncan C; Zantek N; Vittorio J; Angelo J; McArthur J; Schadler K; Chan S; Tewari P; Khazal S; Auletta JJ; Choi SW; Shoberu B; Kalwak K; Harden A; Kebriaei P; Abe JI; Li S; Moffet JR; Abraham S; Tambaro FP; Kleinschmidt K; Richardson PG; Corbacioglu S;
Lancet Haematol; 2020 Jan; 7(1):e61-e72. PubMed ID: 31818728
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
